NIH-funded research R01 grant

Investigating how metabolic processes affect neuron vulnerability in Alzheimer's disease.

Official title: Metabolic Mechanisms in Locus Coeruleus Neuron Vulnerability in Neurodegenerative Disease

Funded at Brown University · NIH-11099836 · Data updated 2026-11-12

This study is looking at how certain brain cells start to break down in Alzheimer's and similar diseases, using a special mouse model to learn more about what makes these cells vulnerable, which could help us understand how these conditions develop over time.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBrown University
NIH-funded
Lab location1 site (Providence, United States)
Project startJune 1, 2024
Project endMarch 31, 2029
Funding year2025
Award (this year)$706,835
NIH project number5R01AG087455-02
Project IDNIH-11099836 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related dementias, particularly those experiencing early symptoms.

Less likely to help

Patients with neurodegenerative disorders not related to Alzheimer's or those who are not experiencing early symptoms may not benefit from this research.

What this research studies

This research focuses on understanding the early degeneration of locus coeruleus neurons in Alzheimer's disease and related neurodegenerative disorders. By studying a specific mouse model that lacks the mitochondrial enzyme GPT2, researchers aim to uncover the metabolic mechanisms that contribute to neuron vulnerability. The approach includes examining how these mechanisms operate across different stages of life and in response to environmental factors. This could lead to insights into the progression of Alzheimer's and similar conditions.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or slowing the progression of Alzheimer's disease and related neurodegenerative disorders.

How similar studies have gone: Previous research has shown promising results in understanding neuron vulnerability in neurodegenerative diseases, but this specific approach using GPT2 is relatively novel.

Where this research is happening

  • Brown University
    Providence, United States
    Active

Researchers

  • Principal investigator: Morrow, Eric M — Brown University
  • Study coordinator: Morrow, Eric M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.